KDM1A was associated with seven drugs, and MAOA with six drugs, many of which were monoamine oxidase inhibitors prescribed for depression and hypertension or PPAR stimulators used in diabetes treatment. This evidence concerns the gene PPARA and depressive symptom measurement.